Open AccessClinico–Epidemio-Microbiological Exploratory Review Among COVID-19 Patients with Secondary Infection in Central India
Author(s) -
T Karuna,
Rahul Garg,
Shweta Kumar,
Gyanendra Pratap Singh,
Lakshmi Prasad,
Kawal Krishen Pandita,
Abhijit Pakhare,
Saurabh Saigal,
Alkesh Kumar Khurana,
Rajnish Joshi,
Kāmini Walia,
Sagar Khadanga
Publication year - 2022
Publication title -
infection and drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s355742
Subject(s) - acinetobacter , pneumonia , medicine , pathogen , concomitant , fluconazole , microbiology and biotechnology , biology , antibiotics , immunology , antifungal
Secondary infections (SI) in COVID-19 have been documented from 3.6% to 72% in various studies with mortality ranging from 8.1% to 57.6%. There is a gap in knowledge for clinico-epidemio-microbilogical association among COVID-19 patients with concomitant SI.